Decrease in the kainate-induced wet dog shake behavior in genetically epilepsy-prone rats: Possible involvement of an impaired synaptic transmission to the 5-HT2A receptor

Journal of Pharmacological Sciences

Volumn 110, Issue 3, 2009, Pages 401-404

  Shin, Eun Joo ^a   Ji, Hoon Jeong ^b   Yoon, Hee Chung ^b   Kim, Tae Woo ^a   Chan, Young Shin ^c   Kim, Won Ki ^d   Ko, Kwang Ho ^e   Kim, Hyoung Chun ^a  

^a Kangwon National University   (South Korea)

^b Chung Ang University   (South Korea)

^c Konkuk University School of Medicine   (South Korea)

^d Korea University College of Medicine   (South Korea)

^e Seoul National University   (South Korea)

Author keywords

Genetically epilepsy prone rat; Kainic acid; Wet dog shake

Indexed keywords

ACTIVITY REGULATED CYTOSKELETON ASSOCIATED PROTEIN; KAINIC ACID; SEROTONIN 2A RECEPTOR;

ARTICLE; HIPPOCAMPUS; NONHUMAN; PROTEIN EXPRESSION; STRAIN DIFFERENCE; SYNAPTIC TRANSMISSION; WET DOG SHAKES;

EID: 67749120525     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.09015SC     Document Type: Article

References (13)

1. Dailey JW, Reigel CE, Mishra PK, Jobe PC. Neurobiology of seizure predisposition in the genetically epilepsy-prone rat. Epilepsy Res. 1989;3:3-17. (Pubitemid 19009365)
2. Ryu JR, Shin CY, Park KH, Jeon GS, Kim HC, WK Kim, et al. Effect of repeated seizure experiences on tyrosine hydroxylase immunoreactivities in the brain of genetically epilepsy-prone rats. Brain Res Bull. 2000;53:777-782.
3. Dursun SM, Handley SL. Similarities in the pharmacology of spontaneous and DOI-induced head-shakes suggest 5HT2A receptors are active under physiological conditions. Psychopharmacology (Berl). 1996;128:198-205.
4. Yap CY, Taylor DA. Involvement of 5-HT2 receptors in the wet-dog shake behaviour induced by 5-hydroxytryptophan in the rat. Neuropharmacology. 1983;22:801-804.
5. Tzingounis AV, Nicoll RA. Arc/Arg3.1: Linking gene expression to synaptic plasticity and memory. Neuron. 2006;52:403-407.
6. Steward O, Wallace CS, Lyford GL, Worley PF. Synaptic activation causes the mRNA for the IEG Arc to localize selectively near activated postsynaptic sites on dendrites. Neuron. 1998;21:741-751. (Pubitemid 28498783)
7. Alme MN, Wibrand K, Dagestad G, Bramham CR. Chronic fluoxitine treatment induces brain region-specific upregulation of genes associated with BDNF-induced long-term potentiation. Neural Plast. 2007;2007:26496. (Pubitemid 350226804)
8. Shin EJ, Ko KH, Kim WK, Chae JS, Yen TP, Kim HJ, et al. Role of glutathione peroxidase in the ontogeny of hippocampal oxidative stress and kainate seizure sensitivity in the genetically epilepsy-prone rats. Neurochem Int. 2008;52:1134-1147.
9. Racine RJ. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol. 1972;32:281-294.
10. Li L, Carter J, Gao X, Whitehead J, Tourtellotte. The neuroplasticity- associated Arc gene is a direct transcriptional target of early growth response (Egr) transcription factors. Mol Cell Biol. 2005;25:10286-10300.
11. Pei Q, Lewis L, Sprakes ME, Jones EJ, Grahame-Smith DG, Zetterstrom TSC. Serotonergic regulation of mRNA expression of Arc, an immediate early gene selectively localized at neuronal dendrites. Neuropharmacology. 2000;39:463-470. (Pubitemid 30052935)
12. Pei Q, Zetterstrom TS, Sprakes M, Tordera R, Sharp T. Antidepressant drug treatment induces Arc gene expression in the rat brain. Neuroscience. 2003;121:975-982. (Pubitemid 37324596)
13. Steward O, Worley PF. Selective targeting of newly synthesized Arc mRNA to active synapses requires NMDA receptor activation. Neuron. 2001;30:227-240. (Pubitemid 32441689)